We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+1.91%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.7B
AUM Growth
+$101M
Cap. Flow
+$158M
Cap. Flow %
1.07%
Top 10 Hldgs %
22.11%
Holding
946
New
64
Increased
332
Reduced
304
Closed
69

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$57.5M
2
AZN icon
AstraZeneca
AZN
+$44.9M
3
ADSK icon
Autodesk
ADSK
+$43.5M
4
MELI icon
Mercado Libre
MELI
+$40.7M
5
AMGN icon
Amgen
AMGN
+$33.6M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$92.5M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$88M
3
BABA icon
Alibaba
BABA
+$73.8M
4
MRK icon
Merck
MRK
+$49.8M
5
MXIM
Maxim Integrated Products
MXIM
+$48.5M

Sector Composition

Rank Sector Weight
1 Healthcare 32.09%
2 Technology 24.53%
3 Financials 9.08%
4 Communication Services 8.24%
5 Consumer Discretionary 7.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VMW
126
DELISTED
VMware, Inc
VMW
$28.4M 0.19%
190,995
+38,638
+25% +$5.86M
HALO icon
127
Halozyme
HALO
$9.9B
$28.4M 0.19%
697,979
+149,049
+27% +$6.23M
NEE icon
128
NextEra Energy
NEE
$188B
$28.3M 0.19%
360,861
-169,379
-32% -$13.7M
INTC icon
129
Intel
INTC
$430B
$28.3M 0.19%
531,707
+218,827
+70% +$11.9M
IDXX icon
130
Idexx Laboratories
IDXX
$45.1B
$27.3M 0.19%
43,826
-6,100
-12% -$4.1M
PEP icon
131
PepsiCo
PEP
$196B
$26.7M 0.18%
177,443
-4,090
-2% -$633K
MTZ icon
132
MasTec
MTZ
$24.4B
$26.7M 0.18%
309,193
+131,645
+74% +$12.5M
TECH icon
133
Bio-Techne
TECH
$11.2B
$26.3M 0.18%
217,464
-27,788
-11% -$3.38M
CDNS icon
134
Cadence Design Systems
CDNS
$95.4B
$26.2M 0.18%
173,202
-5,050
-3% -$770K
NUAN
135
DELISTED
Nuance Communications, Inc.
NUAN
$26.1M 0.18%
474,152
+55,534
+13% +$3.05M
SPLK
136
DELISTED
Splunk Inc
SPLK
$26.1M 0.18%
180,140
-58,749
-25% -$8.55M
AVGO icon
137
Broadcom
AVGO
$1.8T
$25.3M 0.17%
522,590
+75,820
+17% +$3.69M
MTD icon
138
Mettler-Toledo International
MTD
$27.5B
$25.3M 0.17%
18,345
-61
-0.3% -$91.8K
ALNY icon
139
Alnylam Pharmaceuticals
ALNY
$38.4B
$25.1M 0.17%
133,079
-41,743
-24% -$7.83M
SHW icon
140
Sherwin-Williams
SHW
$86.5B
$24.4M 0.17%
87,312
+3,713
+4% +$1.09M
IONS icon
141
Ionis Pharmaceuticals
IONS
$9.06B
$24.4M 0.17%
726,359
+173,793
+31% +$6.55M
CRIS icon
142
Curis
CRIS
$9.32M
$24.3M 0.17%
7,556
+1,356
+22% +$4.23M
INSM icon
143
Insmed
INSM
$22.6B
$24.2M 0.16%
879,547
+374,306
+74% +$9.82M
POWI icon
144
Power Integrations
POWI
$3.27B
$24.1M 0.16%
243,579
-30,208
-11% -$2.93M
DCPH
145
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$24.1M 0.16%
708,117
– –
NVAX icon
146
Novavax
NVAX
$1.19B
$24M 0.16%
115,779
-7,544
-6% -$1.66M
SEDG icon
147
SolarEdge
SEDG
$2.34B
$23.7M 0.16%
89,511
+18,783
+27% +$5.11M
ITW icon
148
Illinois Tool Works
ITW
$85.8B
$23.5M 0.16%
113,701
-1,526
-1% -$344K
AMT icon
149
American Tower
AMT
$82.1B
$23.3M 0.16%
87,944
+50,926
+138% +$14.5M
CL icon
150
Colgate-Palmolive
CL
$75.6B
$23.2M 0.16%
307,416
+48,273
+19% +$3.83M
4 5
6
7 8

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2021 Portfolio in Review

As of Q3 2021, Candriam SCA held 946 positions worth $14.7B, up 0.69% from $14.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA's Q3 2021 filing shows 64 new, 332 increased, 304 reduced and 69 closed positions. Its largest new stake was FIVE9: 86,075 shares worth $13.7M. The largest sale was Alexion Pharmaceuticals, an estimated $92.5M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q3 2021 buy was FIVE9: 86,075 shares worth $13.7M.
  • Candriam SCA added most to Johnson & Johnson in Q3 2021, an estimated $57.5M increase.
  • Candriam SCA's biggest Q3 2021 reduction was Regeneron Pharmaceuticals, cutting an estimated $88M.
  • Candriam SCA fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $92.5M.
  • Candriam SCA's ten largest holdings make up 22% of its $14.7B portfolio in Q3 2021.
  • Candriam SCA opened 64 new positions and closed 69 in Q3 2021.
  • Candriam SCA's portfolio value rose 0.69% quarter-over-quarter to $14.7B.

Based on Candriam SCA's 13F filing for Q3 2021, filed 9 Nov 2021.